Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - BioCardia, Inc. | Financial_Report.xls |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
Amendment No. 2
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2011
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________to _________
Commission file number: 0-21419
Tiger X Medical, Inc.
(Exact name of Registrant as Specified in its Charter)
|
|
|
|
|
|
7625 Hayvenhurst Avenue, Suite #49
Van Nuys, CA 91406
(Address of Principal Executive Offices including Zip Code)
(310) 987-7345
(Registrant's Telephone Number, Including Area Code)
Cardo Medical. Inc.
(Former name, former address and former fiscal year, if changed since last report) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days.
YES x NO ¨ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES x NO ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
|
Large accelerated filer ¨ |
Accelerated filer ¨ |
Non-accelerated filer ¨
|
Smaller reporting company x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
As of November 14, 2011, 230,293,141 shares of the issuer's common stock, par value of $0.001 per share, were outstanding.
EXPLANATORY NOTE IN ACCORDANCE WITH RULE 201 OF REGULATION S-T, THIS AMENDMENT NO. 2 TO THE
FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2011 IS BEING FILED PURSUANT TO A
TEMPORARY HARDSHIP EXEMPTION. This Amendment No. 2 to the Tiger X Medical, Inc. (the "Company") Quarterly Report on Form 10-Q
for the period ended June 30, 2011, as filed with the Securities and Exchange Commission on August 11, 2011 and amended by
Amendment No. 1 on November 15, 2011 (collectively, the "Form 10-Q"), is being filed solely to furnish the interactive data
files as Exhibit 101 to the Form 10-Q as required by Rule 405 of Regulation S-T. The Company was unable to submit the interactive data files with Amendment No. 1 filed on
November 15, 2011 as a result of unanticipated technical difficulties experienced by the Company's third party provider of financial printing services. No changes have been made to the Form 10-Q other than the furnishing of Exhibit 101 described above. This
Amendment No. 2 to Form 10-Q does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify or
update in any way disclosures made in the Form 10-Q. Accordingly, this Amendment No. 2 should be read in conjunction with the
original Form 10-Q, as amended by Amendment No. 1, as well as the Company's other filings made with the Securities and Exchange
Commission pursuant to Section 13(a) or 15(d) of the Exchange Act subsequent to the original Form 10-Q and Amendment No. 1.
The following exhibits are filed as part of, or incorporated by reference into this Report: Exhibit Exhibit Title 2.6 Asset Purchase Agreement, dated as of April 4, 2011, by and among Cardo Medical, Inc., Cardo Medical,
LLC and Altus Partners, LLC (incorporated by reference to Exhibit 2.1 to Form 8-K filed on April 8, 2011) 3.4 Certificate of Amendment to Amended and Restated Certificate of Incorporation of Cardo Medical, Inc.,
dated June 10, 2011 (incorporated by reference to Exhibit 3.1 to Form 8-K filed on June 16, 2011) 31.1 Certification of Chief Executive Officer of Tiger X Medical, Inc., as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002 * 31.2 Certification of Chief Financial Officer of Tiger X Medical, Inc., as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002 * 32.1 Certification of Chief Executive Officer of Tiger X Medical, Inc. pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ** 32.2 Certification of Chief Financial Officer of Tiger X Medical, Inc. pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ** 101.INS*** XBRL Instance Document 101.SCH*** XBRL Taxonomy Extension Schema Document 101.CAL*** XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF*** XBRL Taxonomy Extension Definition Linkbase Document 101.LAB*** XBRL Taxonomy Extension Label Linkbase Document 101.PRE*** XBRL Taxonomy Extension Presentation Linkbase Document * Filed with Amendment No. 1 to the Form 10-Q on November 15, 2011. ** Furnished with Amendment No. 1 to the Form 10-Q on November 15, 2011. *** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a
registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the
Securities Act of 1934 and otherwise not subject to liability. 17
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized. TIGER X MEDICAL, INC. November 17, 2011 By: /s/ Andrew A. Brooks Andrew A. Brooks Chief Executive Officer and Interim Chief Financial Officer (Principal Financial and Accounting Officer)
YES ¨
NO x
Number
(Principal Executive Officer)
INDEX TO EXHIBITS
|
Exhibit |
Exhibit Title |
|
|
101.INS*** |
XBRL Instance Document |
|
|
101.SCH*** |
XBRL Taxonomy Extension Schema Document |
|
|
101.CAL*** |
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
101.DEF*** |
XBRL Taxonomy Extension Definition Linkbase Document |
|
|
101.LAB*** |
XBRL Taxonomy Extension Label Linkbase Document |
|
|
101.PRE*** |
XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
*** |
Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability. |